Generic Pharma group spent $508K on lobbying in 2Q

NEW YORK -- The Generic Pharmaceutical Association spent about $508,000 in the second quarter as it lobbied the federal government on health care reform and issues related to patents on prescription drugs.

How Pfizer Saved Millions by Dumping Its Retirees on Medicare

A change in Pfizer’s (PFE) healthcare benefits is saving the company hundreds of millions of dollars but leaving retirees mostly dependent on Medicare and their own money unless they suffer a catastrophic illness.

Lipitor Generic Rights May Be Sold Should Ranbaxy’s Approval Come Too Late